# A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

> **NCT00367432** · PHASE3 · COMPLETED · sponsor: **UCB Japan Co. Ltd.** · enrollment: 398 (actual)

## Conditions studied

- Epilepsies
- Partial

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00367432
- **Lead sponsor:** UCB Japan Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367432, "A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00367432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*